Point72 Middle East Fze Eagle Pharmaceuticals, Inc. Transaction History

Point72 Middle East Fze

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $7,264 - $23,864	1,569 Added 31.54%	6,543 $34,000
Q3 2023 Nov 14, 2023	BUY	$15.21 - $22.88 $75,654 - $113,805	4,974 New	4,974 $78,000
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $23,706 - $32,249	-946 Reduced 52.29%	863 $24,000
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $45,188 - $71,943	1,809 New	1,809 $0

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.